%0 Conference Paper %B Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications %D 2001 %T Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. %A Jussila, L. %A Veikkola, T. %A Jeltsch, M. %A Thurston, G. %A McDonald, D. %A Achen, M. %A Stacker, S. %A Alitalo, K. %B Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications %C Miami Beach, Florida %8 2001/10/29/ %G eng